FIELD: medicine. SUBSTANCE: the suggested composition includes EGF as an active ingredient and carboxyvinyl polymer as a foundation. It is established that EGF preparation is of considerable stability. Thus, the composition is useful as ophthalmologic compositions, composition for local application on skin, cosmetic compositions, etc. EFFECT: higher efficiency. 9 cl, 8 ex, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR TOPICAL USAGE CONTAINING HUMAN EPIDERMIS FACTOR GROWTH | 1998 |
|
RU2202362C2 |
| APPLICATION OF LOCAL COMPOSITION, CONTAINING EPIDERMAL GROWTH FACTOR (EGF), FOR PREVENTION OF AMPUTATION CAUSED BY DIABETIC FOOT | 2006 |
|
RU2394590C2 |
| LYOPHILIZED IMMUNOCYTOKINE-CONTAINING PREPARATION | 2003 |
|
RU2316348C2 |
| PHARMACEUTICAL COMPOSITION OF ANTITUMOR ACTIVITY (VERSIONS) AND METHOD FOR ITS OBTAINING (VERSIONS) | 1999 |
|
RU2201759C2 |
| LOXOPROFEN-CONTAINING PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR INJECTIONS | 2001 |
|
RU2232572C2 |
| COMBINED AGENT FOR INTRAARTICULAR ADMINISTRATION | 2017 |
|
RU2737380C2 |
| NANOLIPOSOME WITH APPLICATION OF ETHERIFICATED LECITIN AND METHOD OF OBTAINING SUCH, AS WELL AS COMPOSITION FOR PREVENTION OR TREATMENT OF SKIN DISEASES INCLUDING SUCH LIPOSOMES | 2007 |
|
RU2418575C2 |
| ECTEINASCIDIN AND DISACCHARIDE-CONTAINING COMPOSITIONS | 2005 |
|
RU2382647C2 |
| OPHTHALMIC COMPOSITION BASED ON AQUEOUS SOLUTION OF ION- SENSITIVE HYDROPHILIC POLYMER (VARIANTS) | 1995 |
|
RU2139016C1 |
| EYE DROPS | 1991 |
|
RU2068260C1 |
